Maze Therapeutics, Inc.

MAZE · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$316,773$264,541$294,374$196,812
Short-Term Investments$67,162$0$0$0
Receivables$700$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$6,667$6,609$5,333$4,859
Total Curr. Assets$391,302$271,150$299,707$201,671
Property Plant & Equip (Net)$26,458$27,713$28,797$29,918
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$1,089$1,089$1,089$1,088
Tax Assets$0$0$0$0
Other NC Assets$3,209$3,567$3,247$7,865
Total NC Assets$30,756$32,369$33,133$38,871
Other Assets$0$0$0$0
Total Assets$422,058$303,519$332,840$240,542
Liabilities
Payables$2,918$3,666$2,404$1,939
Short-Term Debt$4,764$4,718$4,674$4,632
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$14,430$11,516$11,539$14,102
Total Curr. Liab.$22,112$19,900$18,617$20,673
LT Debt$19,419$20,291$21,149$21,996
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,091$1,090$1,006$969
Total NC Liab.$20,510$21,381$22,155$22,965
Other Liabilities$0$0$0$0
Cap. Leases$24,183$25,009$25,823$26,628
Total Liabilities$42,622$41,281$40,772$43,638
Equity
Pref Stock$0$0$0$508,087
Common Stock$48$44$44$2
Retained Earnings-$454,979-$424,892-$391,213-$358,427
AOCI$69$0$0$0
Other Equity$834,298$687,086$683,237$47,242
Total Equity$379,436$262,238$292,068$196,904
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$422,058$303,519$332,840$240,542
Net Debt-$292,590-$239,532-$268,551-$170,184